Immuneering (IMRX) Other Operating Expenses (2022 - 2026)

Immuneering's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to $7317.0; the TTM figure through Mar 2026 stood at $29268.0 (changed 0.0% YoY), while the FY2025 annual figure was $29267.0, changed 0.0% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $7317.0, roughly flat from $7317.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $8103.0 in Q1 2022, with the low at $7316.0 in Q4 2022.
• The 5-year median for Other Operating Expenses is $7317.0 (2022), against an average of $7363.2.
• Peak annual rise in Other Operating Expenses reached 0.01% in 2023, while the deepest fall reached 9.7% in 2023.
• Immuneering's Other Operating Expenses stood at $7316.0 in 2022, then rose by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
• Business Quant data shows IMRX's Other Operating Expenses at $7317.0 in Q1 2026, $7317.0 in Q4 2025, and $7317.0 in Q3 2025.